空间分辨亚漫反射光谱定量胃黏膜微循环作为门脉高压替代标志物诊断肝硬化
这项概念验证研究用空间分辨亚漫反射光谱(SRSRS)在内镜下正常的胃底取10次测量,比较肝硬化患者(n=18)与无肝病对照(n=18)的黏膜微循环。肝硬化组浅层血容量分数(P=.06)和亚漫反射(P=.02)更高,联合光学标志物区分肝硬化的敏感度72%、特异度94%(AUC 0.82)。
要点
- SRSRS可在内镜下正常胃底定量黏膜微循环。
- 联合光学标志物区分肝硬化敏感度72%、特异度94%、AUC 0.82。
- 浅层亚漫反射在肝硬化组更高(P=.02),血容量分数差异未达显著(P=.06)。
核心结论
- 胃底黏膜微循环的光谱定量是有前景的门脉高压临床替代标志物。
- 该方法可能成为肝病预后及治疗反应的较少侵入性替代生物标志物。
研究设计与样本
- 概念验证研究,因临床指征行EGD时用SRSRS探头在胃底取10次测量。
- 肝硬化组n=18,无肝病对照组n=18,并以瞬时弹性成像佐证分组。
主要发现
- 肝硬化组胃底浅层血容量分数高于对照组,P=.06。
- 肝硬化组胃底浅层亚漫反射高于对照组,P=.02。
- 联合光学标志物区分肝硬化与对照的敏感度72%、特异度94%,AUC 0.82。
关键数值与推荐
- 联合光学标志物诊断肝硬化的敏感度72%、特异度94%、AUC 0.82。
- 浅层血容量分数组间比较P=.06,浅层亚漫反射组间比较P=.02。
临床怎么用
- 可作为门脉高压临床相关表现的较少侵入性替代评估思路。
- 潜在用于肝病预后判断及治疗反应监测,尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Portal pressure can be used to identify patients with chronic liver disease who have progressed to cirrhosis. Portal pressure can also provide accurate prognostication for patients with cirrhosis. However, there are no practical means for assessment of portal pressure. Although it is well established that the gastric mucosal blood supply increases in patients with cirrhosis, this has been difficult to quantify reproducibly. Our group has developed a novel spectroscopic technology called spatially resolved subdiffuse reflectance spectroscopy (SRSRS), which enables quantification of mucosal microcirculation. We aim to ascertain if quantification of the gastric mucosal microcirculation with SRSRS correlates with clinical evidence of portal hypertension. METHODS: Patients undergoing EGD for clinical indications had 10 measurements taken in the endoscopically normal gastric fundus via SRSRS probe to assess the microcirculation. Cases were defined as patients with cirrhosis (n = 18), and controls were those without evidence of liver disease (n = 18); this was corroborated with transient elastography. RESULTS: The blood volume fraction (P = .06) and subdiffuse reflectance (P = .02) from a shallow depth in the gastric fundus were higher in patients with cirrhosis than those without. These markers were combined to yield an overall optical marker that can differentiate patients with cirrhosis from controls with a sensitivity of 72% and specificity of 94% (area under receiver operating curve, 0.82). CONCLUSIONS: Spectroscopic quantification of gastric fundal mucosal microcirculation is a promising surrogate of clinical correlates of portal hypertension. This approach may represent a less-intrusive surrogate biomarker for liver disease prognostication and potentially response to therapy.
引用
- Mohanty A, Eshein A, Kamineni P, et al. Quantification of gastric mucosal microcirculation as a surrogate marker of portal hypertension by spatially resolved subdiffuse reflectance spectroscopy in diagnosis of cirrhosis: a proof-of-concept study. Gastrointest Endosc. 2020. PMID: 33385462. doi:10.1016/j.gie.2020.12.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。